Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?: Difference between revisions

From Iskomunidad
Pasy (talk | contribs)
mNo edit summary
Pasy (talk | contribs)
No edit summary
Line 6: Line 6:
University of the Philippines - Manila<br /><br />
University of the Philippines - Manila<br /><br />


Webpage shortcut: '''[http://goo.gl/xszDH goo.gl/xszDH]'''
<br /><br />
'''Resource Person'''<br />
'''Resource Person'''<br />
[http://www.bioethics.nih.gov/people/cv/Lie_CV_Nov11.pdf Dr Reidar K. Lie]<br />
[http://www.bioethics.nih.gov/people/cv/Lie_CV_Nov11.pdf Dr Reidar K. Lie]<br />

Revision as of 22:04, 26 October 2012

"Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"
10 December 2012 (Monday), 2pm
Buenafe Hall
College of Medicine
University of the Philippines - Manila

Webpage shortcut: goo.gl/xszDH

Resource Person
Dr Reidar K. Lie
Adjunct Research Fellow
Department of Bioethics
Clinical Center
National Institutes of Health, USA

See Also

“Ethical, Legal, Social Issues” (ELSI) Program, Philippine Genome Center